Tvardi Therapeutics, Inc. (TVRD)
3.86
-0.09
(-2.28%)
USD |
NASDAQ |
Feb 04, 16:00
3.84
-0.02
(-0.52%)
After-Hours: 20:00
Tvardi Therapeutics EPS Diluted (Quarterly) : -0.5894 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.567 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.527M |
| Total Expenses (Quarterly) | 5.527M |
| Enterprise Value | -0.0202M |
| Earnings Yield | -255.2% |
| Normalized Earnings Yield | -284.06 |